PT  - JOURNAL ARTICLE
AU  - Neelima Penugonda
AU  - Adam Mohmand-Borkowski
AU  - James F. Burke
TI  - Dronedarone for atrial fibrillation: How does it compare with amiodarone?
AID  - 10.3949/ccjm.78a.10049
DP  - 2011 Mar 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 179--185
VI  - 78
IP  - 3
4099  - http://www.ccjm.org/content/78/3/179.short
4100  - http://www.ccjm.org/content/78/3/179.full
SO  - Cleve Clin J Med2011 Mar 01; 78
AB  - Dronedarone (Multaq), an analogue of amiodarone (Cordarone), was designed to cause fewer adverse effects than the parent compound. Studies have indeed shown dronedarone to be safer than amiodarone, but less effective. Its official indication is to reduce the risk of hospitalization in patients with paroxysmal or persistent atrial fibrillation or atrial flutter and other cardiovascular risk factors, reflecting the parameters of its effectiveness in clinical trials.